PMH cancer researchers link ovarian hormone to breast stem cells growth
( University Health Network ) Cancer researchers at Princess Margaret Hospital have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
Read more on EurekAlert!
Terra med Alliance News Doctors and experts are in uproar over new recommendations to raise the age of breast cancer screening, warning more women will die from the disease which already claims some 40,000 lives each year.
Terra med Alliance News : Doctors and experts are in uproar over new recommendations to raise the age of breast cancer screening, warning more women will die from the disease which already claims some 40,000 lives each year.
The high-level United States Preventative Services Task Force of scientists and researchers Monday recommended that breast cancer screening in women should now start at the age of 50 as opposed to 40.
» Read more: Terra med Alliance News US anger at new age rules for breast cancer tests
Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab (Herceptin)–typically used in combination with chemotherapy. However, a new study by researchers at Fox Chase Cancer Center reports that it may be safe to treat these patients with both Trastuzumab and adjuvant radiation therapy.
The study will be presented at the annual meeting of the American Society for Radiation Oncology (ASTRO).
» Read more: Terramed Alliance News Safe To Treat HER2-positive Breast Cancer